Disarib, a Specific BCL2 Inhibitor - Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression - Altering Mitochondria-Associated Processes
Favorite
Share
More Options
25

Open in WPS to view all 25 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
